Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Toltrazuril
Lavet Pharmaceuticals Ltd
QP51AJ01
Toltrazuril
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Pigs
Antiprotozoal anticoccidial
Authorized
2012-04-04
Revised: March 2021 AN: 01793/2020 & 01795/2020 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Toltramax 50 mg/ml oral suspension for pigs Toltrazuril 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Toltrazuril 50 mg EXCIPIENTS: Sodium benzoate (E211) 2 mg Sodium propionate (E281) 2 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. White or almost white suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pig (Piglets 3 to 5 days old). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the prevention of clinical signs of coccidiosis in neonatal piglets (3 to 5 days old) on farms with a confirmed history of coccidiosis caused by _Isospora suis_. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES As with any antiparasiticide, frequent and repeated use of antiprotozoals from the same class may lead to the development of resistance. It is recommended to treat all animals in a pen. Revised: March 2021 AN: 01793/2020 & 01795/2020 Page 2 of 4 Hygienic measures may reduce the risk of coccidiosis. It is therefore, recommended to improve concomitantly the hygienic conditions in the concerned facility, particularly dryness and cleanliness. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS To alter the course of an established clinical coccidial infection, in individual animals already showing signs of diarrhoea, additional supportive therapy may be required. II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician. This product may cause allergic reactions in those that are sensitive. People with known hypersensitivity to toltrazuril should avoid contact with the product. The product may cause irrita Read the complete document